Compare ALLO & ALIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | ALIT |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 452.6M | 394.4M |
| IPO Year | 2018 | 2020 |
| Metric | ALLO | ALIT |
|---|---|---|
| Price | $1.22 | $9.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 5 |
| Target Price | $9.00 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 5.2M | 442.2K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 8.79% |
| EPS Growth | ★ 34.09 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,262,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $255.46 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.04 | $0.48 |
| 52 Week High | $4.46 | $23.68 |
| Indicator | ALLO | ALIT |
|---|---|---|
| Relative Strength Index (RSI) | 24.71 | 44.85 |
| Support Level | N/A | $8.51 |
| Resistance Level | $2.22 | $10.10 |
| Average True Range (ATR) | 0.08 | 0.71 |
| MACD | -0.00 | 0.15 |
| Stochastic Oscillator | 0.00 | 69.35 |
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
Alight Inc is a technology-enabled services company delivering human capital management solutions to many complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth, and leave benefits) solutions, which currently operate under one reportable segment, Employer Solutions. The Employer Solutions segment is driven by the Alight Worklife platform, and includes integrated benefits administration, healthcare navigation, financial well-being, leave of absence management, and retiree healthcare. Geographically, the company generates the majority of its revenue from the United States.